WELCOME
THIRD GLOBAL INDIAN ENTREPRENEURS CONFERENCE, NEW YORK, September, 12 -15 th, 2002
Enormous Power – A Simple Use! ?
Definition Any tecnique, product or process which uses or is derived by using any living system ( plant, animal or microoragnism ), to make or modify a product, to improve plants or animals , to develop micro-organisms for specific use.
http: //www. accessexcellence. org/AB/GG/biotechnology. html
Global Biotech $3 Billion Global Biotech $250 Billion. Bio Drugs $25 Billion Sunday, April 21, 2002 IITOL Special Report http: //www. ey. com/GLOBAL/gcr. nsf/International/Biotech_Interview_Forum_-_Healthcare_-_Ernst_&_Young
Biotechnology- Global Promise • The global biotechnology industry consists of approximately 1, 500 companies with industry revenues of USD 18 billion and a market capitalization exceeding USD 300 billion (1999 figures) • The global biotechnology industry is expected to grow to USD 400 billion by year 2005 • USFDA has approved 90 biotech products and over 2, 200 products are in development
Bangalore Bio 2002 15 -17 th April 56 Exhibitors 300 Conference Delegates 12, 000 Business Visitors 24, 000 general Visitors
The India Advantage • India offers significant advantages for research in biotechnology – Vast pool of talented and skilled man power – Several leading research institutions – Large and diverse gene pool - plant and human – Vast and naïve patient population essential for new drug development – Lower operational costs and technologies – English as the accepted business language – Complementary competencies in BT and IT making India well positioned to exploit the Bio informatics wave
Biotechnology in India • Biotechnology in India at a nascent stage • Industry size estimated at US$ 3 billion (2002) • Total biotech product market expected to grow 20% /year • The Indian biotech industry employs about 10, 000 people; this number is expected to grow to 20, 000 by 2002
http: //www. pharmabiz. com/specials/Bio. Asia 1. asp
Biotech market in India, $m Animal & health-care products 2000 2005* Vaccines 150 300 Antibiotics 225 275 Other 200 350 - - High-yielding & genetically modified seeds 450 650 Other 100 200 Industrial products - - Industrial enzymes 50 100 Amino acids, organic acids 150 200 Yeast and yeast products 150 250 Total 1, 475 2, 325 Source: Biocon India *Forecast Agricultural products
COMPANY PRODUCTS Avesthagen Technologies Plant genomics, GM Rice, Contract Research Bangalore Genei Restriction enzymes, plasmids, bacterial host strains, gel documentation systems etc. Bharat Biotech Hep B Vaccine, GCSF, Interferon, Streptokinase Biocon India Enzymes, Lepuridine, Gamma Interferon, GCSF, Streptokinase, Human Insulin, Monoclonal antibodies. Clinigene International Human genomics, Bioinformatics : Contract Clinical Research Dr Reddy's(DRL) GCSF, Interferon Genotypic Technologies Array based HTS contract research Lotus Labs Clinical trials: Contract research MAHYCO GM seeds: Bt Cotton Panacea Biotech Hep B Vaccine, Interferon, GCSF Pro-Agro Seeds GM Crops, Bt cotton Photonics & Biomolecules Laser based diagnostics Reliance Industries Stem cell research Strand Genomics Bioinformatics based contract research services Synegene International Disease Targets, r-DNA proteins, animal cell & tissue culture : Contract Research Syngenta GM seeds Wockhardt Hep B Vaccine, EPO, GCSF, Human Insulin X-Cyton Recombinant diagnostics for AIDS, Hep C etc.
Growth areas for India - Biogenerics - Contract research - Contract manufacturing - Clinical trials - Genomics – Bio-informatics – Diagnostics – Drug discovery and – Novel drug delivery systems.
Biotechnology - Future Technology • Biotechnology is a highly specialized segment of the life sciences industry • Benefits range from product development in pharmaceuticals and healthcare, sustainable agriculture to solving problems of land water pollution • Growing global population putting tremendous pressure on large pharmaceutical companies for innovative new drugs • Biotechnology industry seen as a key growth driver for the pharmaceutical industry
Future Treatment
Plant Biotechnology
Hope we have a lot ahead So close, but behind. So dear, but with fear ! Nope, we can’t turn back But to march ahead!
Thanks ! for your coperation in sharing information Namastae ! The greatness in me is a reflection of Greatness in you !
Srinivasa K. Rao, Ph. D. , Chief, Bussiness & Technology Development. SHANTHA BIOTECHNICS Post Box No. 40137, Glen Oaks. NEW YORK, 11005 Tel: 516 859 3010 Res : 718 347 9070 Email: srao@shanthabiotech. com SHANTHA GROUP: Shantha Biotechnics Pvt. Ltd. Hyderabad, India Shantha Marine, Chennai, India Shantha West Inc, San Diego, USA
Скачать презентацию WELCOME THIRD GLOBAL INDIAN ENTREPRENEURS CONFERENCE
8a2e04536dc7e8014e7e8efd1024a7e3.ppt